Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1159/000513400 http://scihub22266oqcxt.onion/10.1159/000513400 33406518!7900480!33406518     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Gerontology 2021 ; 67 (3): 255-266 Nephropedia Template TP {{tp|p=33406518|t=2021. The Clinical Characteristics and Risk Factors of Severe COVID-19 |pdf=|usr=}}{{33406518}} gab.com Text The Clinical Characteristics and Risk Factors of Severe COVID-19 JO: Gerontology http://www.kidney.de/pget.php?&tw=1&pmid=33406518 #FOAvip OBJECTIVE: We aim to investigate the clinical characteristics and risk factors for the severe cases of coronavirus disease 2019 (COVID-19) in comparison with the non-severe patients. METHODS: We searched PubMed, EMBASE, Web of Science, and CNKI to collect all relevant studies published before July 26, 2020, and a total of 30 papers were included in this meta-analysis. RESULTS: In the severe COVID-19 patients, 60% (95% CI = 56-64%) were male, 25% (95% CI = 21-29%) were over 65 years old, 34% (95% CI = 24-44%) were obese, and 55% (95% CI = 41-70%) had comorbidities. The most prevalent comorbidities were hypertension (34%, 95% CI = 25-44%), diabetes (20%, 95% CI = 15-25%), and cardiovascular disease (CVD; 12%, 95% CI = 9-16%). The most common blood test abnormalities were elevated C-reactive protein (CRP; 87%, 82-92%), decreased lymphocyte count (68%, 58-77%), and increased lactate dehydrogenase (69%, 95% CI = 57-81%). In addition, abnormal laboratory findings revealing organ dysfunctions were frequently observed in the severe cases, including decrease in albumin (43%, 95% CI = 24-63%) and increase in aspartate aminotransferase (47%, 95% CI = 38-56%), alanine aminotransferase (28%, 95% CI = 16-39%), troponin I/troponin T (TnI/TnT; 29%, 95% CI = 13-45%), and serum Cr (SCr; 10%, 95% CI = 5-15%). CONCLUSION: The male, elderly and obese patients and those with any comorbidities, especially with hypertension, diabetes, and CVD, were more likely to develop into severe cases. But the association between hypertension, diabetes, CVD, and severity of COVID-19 was declined by the increase of age. A significant elevation in cardiac TnI/TnT, the hepatic enzymes, and SCr and the reduction in lymphocytes with elevated CRPs are important markers for the severity. Specific attention should be given to the elderly male and obese patients and those with indications of severe immune injury in combination with bacterial infection and indication of multi-organ dysfunction or damages. Twit Text FOAVip The Clinical Characteristics and Risk Factors of Severe COVID-19 ????Gerontology http://www.kidney.de/pget.php?&tw=1&pmid=33406518 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33406518 #FOAvip English Wikipedia <ref>{{Cite pmid|33406518}}</ref> The Clinical Characteristics and Risk Factors of Severe COVID-19 #MMPMID33406518 Hu J; Wang Y Gerontology 2021[]; 67 (3): 255-266 PMID33406518show ga OBJECTIVE: We aim to investigate the clinical characteristics and risk factors for the severe cases of coronavirus disease 2019 (COVID-19) in comparison with the non-severe patients. METHODS: We searched PubMed, EMBASE, Web of Science, and CNKI to collect all relevant studies published before July 26, 2020, and a total of 30 papers were included in this meta-analysis. RESULTS: In the severe COVID-19 patients, 60% (95% CI = 56-64%) were male, 25% (95% CI = 21-29%) were over 65 years old, 34% (95% CI = 24-44%) were obese, and 55% (95% CI = 41-70%) had comorbidities. The most prevalent comorbidities were hypertension (34%, 95% CI = 25-44%), diabetes (20%, 95% CI = 15-25%), and cardiovascular disease (CVD; 12%, 95% CI = 9-16%). The most common blood test abnormalities were elevated C-reactive protein (CRP; 87%, 82-92%), decreased lymphocyte count (68%, 58-77%), and increased lactate dehydrogenase (69%, 95% CI = 57-81%). In addition, abnormal laboratory findings revealing organ dysfunctions were frequently observed in the severe cases, including decrease in albumin (43%, 95% CI = 24-63%) and increase in aspartate aminotransferase (47%, 95% CI = 38-56%), alanine aminotransferase (28%, 95% CI = 16-39%), troponin I/troponin T (TnI/TnT; 29%, 95% CI = 13-45%), and serum Cr (SCr; 10%, 95% CI = 5-15%). CONCLUSION: The male, elderly and obese patients and those with any comorbidities, especially with hypertension, diabetes, and CVD, were more likely to develop into severe cases. But the association between hypertension, diabetes, CVD, and severity of COVID-19 was declined by the increase of age. A significant elevation in cardiac TnI/TnT, the hepatic enzymes, and SCr and the reduction in lymphocytes with elevated CRPs are important markers for the severity. Specific attention should be given to the elderly male and obese patients and those with indications of severe immune injury in combination with bacterial infection and indication of multi-organ dysfunction or damages. |Age Distribution[MESH] |Age Factors[MESH] |Aged[MESH] |Alanine Transaminase/metabolism[MESH] |Aspartate Aminotransferases/metabolism[MESH] |C-Reactive Protein/metabolism[MESH] |COVID-19/*epidemiology/*metabolism/physiopathology[MESH] |Cardiovascular Diseases/epidemiology[MESH] |Comorbidity[MESH] |Creatinine/metabolism[MESH] |Diabetes Mellitus/epidemiology[MESH] |Female[MESH] |Humans[MESH] |Hypertension/epidemiology[MESH] |L-Lactate Dehydrogenase/metabolism[MESH] |Lymphopenia[MESH] |Male[MESH] |Middle Aged[MESH] |Obesity/epidemiology[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH] |Sex Distribution[MESH] |Troponin I/metabolism[MESH]The Clinical Characteristics and Risk Factors of Severe COVID-19 (epmc).pdf DeepDyve Pubget Overpricing